Wei-Jie Fang

Title: **Inventor Wei-Jie Fang: Pioneering Stable Glucagon Formulations**

Introduction

Wei-Jie Fang is a notable inventor based in Aurora, Colorado, recognized for his innovative contributions to the field of biopharmaceuticals. With a strong background in research and development, he has made significant strides in improving treatments for hypoglycemia through his patented inventions.

Latest Patents

Wei-Jie Fang holds a patent titled "Stable glucagon formulations for the treatment of hypoglycemia." This groundbreaking patent focuses on the delivery of biopharmaceutical and therapeutic agents to patients through minimally invasive methods. The invention allows for the administration of injectable glucagon, dissolved in a pharmaceutically acceptable carrier, via the epidermal, dermal, or subcutaneous layers of the skin, ensuring a low-pain experience for patients.

Career Highlights

Throughout his career, Wei-Jie Fang has had the opportunity to work with esteemed organizations, including the University of Colorado and Xeris Pharmaceuticals, Inc. His contributions in these environments have paved the way for advancements in biopharmaceutical research and development, particularly in the area of hypoglycemic treatments.

Collaborations

Wei-Jie Fang has collaborated with fellow innovators such as Steven J. Prestrelski and John Frank Carpenter. Their joint efforts in research and development have further enhanced the effectiveness and safety of biopharmaceuticals, contributing to the ongoing improvement of healthcare solutions for patients.

Conclusion

With a commitment to innovation and a focus on patient care, Wei-Jie Fang continues to make impactful contributions to the field of biopharmaceuticals. His patent on stable glucagon formulations exemplifies his dedication to improving treatment methods for individuals suffering from hypoglycemia, ensuring they receive the best possible care.